General Assembly Raised Bill No. 866
January Session, 2017 LCO No. 4303
*_____SB00866GL____030817____*
Referred to Committee on GENERAL LAW
Introduced by:
(GL)
General Assembly
Raised Bill No. 866
January Session, 2017
LCO No. 4303
*_____SB00866GL____030817____*
Referred to Committee on GENERAL LAW
Introduced by:
(GL)
AN ACT CONCERNING CANNABIDIOL PRESCRIPTION MEDICATION.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. (NEW) (Effective July 1, 2017) If a cannabidiol investigational product is newly approved or rescheduled by the federal Food and Drug Administration, as a prescription medication, as defined in section 17b-499 of the general statutes, such investigational product shall be deemed approved as a prescription medication in this state.
This act shall take effect as follows and shall amend the following sections:
Section 1 July 1, 2017 New section
This act shall take effect as follows and shall amend the following sections:
Section 1
July 1, 2017
New section
GL Joint Favorable
GL
Joint Favorable